Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

399 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Active, not recruiting

Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)

NCT05698329

Conditions
Diabetic Macular Edema, Eye Diseases, Macular Degeneration, +4 more
Locations
  • Retina-Vitreous Associates Beverly Hills, California, United States
  • Orange County Retina Santa Ana, California, United States
  • Verum Research Eugene, Oregon, United States
  • Valley Retina Institute McAllen, Texas, United States
View Trial Details
Completed

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease

NCT05244304

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations
  • Belite Study Site Palo Alto, California, United States
  • Belite Study Site Minneapolis, Minnesota, United States
  • Belite Study Site Salt Lake City, Utah, United States
  • Belite Study Site Westmead, New South Wales, Australia
View all 19 locations
View Trial Details
Completed

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

NCT03364153

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations
  • Retinal Research Institute Phoenix, Arizona, United States
  • Jules Stein Eye Institute/ David Geffen School of Medicine Los Angeles, California, United States
  • VitreoRetinal Associates Gainesville, Florida, United States
  • Retina Specialty Institute Pensacola, Florida, United States
View all 41 locations
View Trial Details
Completed

Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.

NCT05959304

Conditions
Diabetic Macular Edema, Eye Diseases, Macular Degeneration, +9 more
Locations
  • Novartis Investigative Site Ahmedabad, Gujarat, India
  • Novartis Investigative Site Bangalore, Karnataka, India
  • Novartis Investigative Site Kochi, Kerala, India
  • Novartis Investigative Site Chennai, Tamil Nadu, India
View Trial Details

Related conditions